Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2023-10-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). This document details the issuance of new shares, the purpose of the capital raise, the third-party allocation details, and the board's resolution. This falls under the category of capital structure changes and financing activities.
2023-10-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is the standard regulatory filing in South Korea (often referred to as the '5% rule' report) for entities that acquire a significant stake in a company. It details the shareholding status, changes in ownership, and the purpose of the holding (management influence). This fits the 'Major Shareholding Notification' category.
2023-09-27 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회소집결의' (Resolution for Convening a General Meeting of Shareholders) and a '정정신고' (Amendment Report). It details the agenda for an upcoming Extraordinary General Meeting, including the appointment of directors. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2023-09-26 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Aprogen Inc. It includes the meeting date, location, agenda items (election of directors), and detailed 'Management Reference Materials' (경영참고사항) which cover board activities, director remuneration, and business overviews. This content is standard for proxy materials sent to shareholders to inform them of upcoming votes. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2023-09-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity's shareholding in a listed company crosses certain thresholds (typically 5%). The document details the reporter (Nichi-Iko Pharmaceutical Co., Ltd.), the issuer (Aprogen), and the changes in share ownership due to market sales. This falls under the category of 'Major Shareholding Notification'.
2023-09-19 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system (KIND) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the acquisition of a patent. Since this document does not fit into specific categories like financial reports, dividends, or board changes, and is a standard regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2023-09-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.